Salivary and Intestinal Complement System Inhibitors in the Midgut Protection of Triatomines and Mosquitoes

The classic pathway is initiated by the binding of C1q, C1r and C1s (the C1 complex) to antibodies linked to the activation surface. The proteolytic activity of C1r is automatically activated by interaction with C1q. C1r then cleaves and activates C1s, which is another serine protease. C1s acts specifically on C2 and C4 activating them. Once cleaved, the fragment C4b is capable to bind covalently to the activation surface creating a binding site to C2a. The active serine protease C2a, in the C4b-C2a complex, acts on C3 producing C3b molecules which are also capable to bind covalently to the activation surface nearby its site of activation. The complex C4b-C2a-C3b acts as a C3 convertase as well as a C5 convertase generating the MAC. For activation of the alternative pathway, a small fraction of C3 present in the extracelular fluids slowly undergoes spontaneous reaction with H2O molecules generating C3-H2O. These molecules can interact with the protein B generating the B-C3-H2O complex which is a substrate for D, a plasmatic serine protease. The Bb-C3-H2O complex acts on C3 cleaving it to C3b and C3a. Most of the C3b molecules generated will combine with H2O or other self molecules becoming inactive. On the other hand, if a C3b molecule is generated near an adequate surface such as a bacterium, it will covalently bind to it creating a binding site for factor B. The C3b-B complex is activated by the protease D generating C3b-Bb, an efficient protease capable to activate other C3 molecules. The complex C3b-Bb-C3b is an efficient C3 convertase as well as a C5 convertase generating the MAC. To simplify, the lectin pathway as well as the normal regulatory proteins were omitted.
Salivary and Intestinal Complement System Inhibitors in the Midgut Protection of Triatomines and Mosquitoes

Publication

The Role of Salivary and Intestinal Complement System Inhibitors in the Midgut Protection of Triatomines and Mosquitoes. (2009) Veruska Cavalcanti Barros, et al. PLoS One. 2009;4(6):e6047. Figure: F4.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Gallus gallus Vertebrates C4a) C4A ncbigene_symbol C4A 418892
Gallus gallus Vertebrates C4 C4 ncbigene_symbol C4 426611
Gallus gallus Vertebrates c2 C2 ncbigene_symbol C2 419574
Gallus gallus Vertebrates С5 C5 ncbigene_symbol C5 417122
Mus musculus Rodents Ba BA ncbigene_symbol ba 12011
Mus musculus Rodents C4a) C4A ncbigene_symbol C4a 625018
Mus musculus Rodents C2b C2B ncbigene_synonym Scgb2b24 233090
Mus musculus Rodents c2 C2 ncbigene_symbol C2 12263
Mus musculus Rodents c14 C14 ncbigene_synonym Amhr2 110542
Mus musculus Rodents Ab AB ncbigene_synonym App 11820
Mus musculus Rodents Ab AB ncbigene_synonym H2-Ab1 14961
Rattus norvegicus Rodents C4a) C4A ncbigene_symbol C4a 24233
Rattus norvegicus Rodents c2 C2 ncbigene_symbol C2 24231
Rattus norvegicus Rodents c14 C14 ncbigene_synonym Amhr2 29530
Rattus norvegicus Rodents Ab AB ncbigene_synonym App 54226
Rattus norvegicus Rodents С5 C5 ncbigene_symbol C5 362119
Homo sapiens Primates C4a) C4A ncbigene_symbol C4A 720
Homo sapiens Primates C2b C2B ncbigene_synonym SCGB2B3P 100130342
Homo sapiens Primates c3a C3A ncbigene_synonym C3 718
Homo sapiens Primates c3a C3A ncbigene_synonym ERVK-2 100616100
Homo sapiens Primates c2 C2 ncbigene_symbol C2 717
Homo sapiens Primates Ab AB ncbigene_synonym APP 351
Homo sapiens Primates Ab AB ncbigene_synonym SUCLA2 8803
Homo sapiens Primates MAC MAC famplex_relations C5 727
Homo sapiens Primates MAC MAC famplex_relations C6 729
Homo sapiens Primates MAC MAC famplex_relations C7 730
Homo sapiens Primates MAC MAC famplex_relations C8A 731
Homo sapiens Primates MAC MAC famplex_relations C8B 732
Homo sapiens Primates MAC MAC famplex_relations C8G 733
Homo sapiens Primates MAC MAC famplex_relations C9 735

Chemical mentions

Word Match MeSH Name ChEBI

Disease mentions

Word Match MeSH Name DOID